IN Brief:
- SuanNutra has agreed to acquire IFF businesses spanning botanical extracts, nutrients, colours, antioxidants, and selected flavours.
- The combined operation will employ around 700 people and serve more than 1,200 customers across over 60 countries.
- Manufacturing will include botanical extraction in Europe and Latin America alongside fermentation capacity in the United States.
SuanNutra has agreed to acquire a portfolio of speciality natural ingredients businesses from IFF, expanding into botanical extracts, fermented nutrients, natural colours, antioxidants, flavours, and food-enhancement systems.
The transaction is expected to complete by the end of 2026, subject to regulatory approvals, consultation requirements, and customary closing conditions. Financial terms have not been disclosed.
Businesses included in the sale generated approximately $170m in revenue during 2025 and employ about 600 people across five manufacturing facilities in Europe, the United States, and Latin America.
Once integrated with SuanNutra’s existing activities, the enlarged group is expected to employ around 700 people and serve more than 1,200 customers in over 60 countries. Its production footprint will include botanical extraction in Spain, Slovenia, and Peru, alongside fermentation capability in the United States.
The transferred portfolio includes clinically supported branded ingredients, plant extracts produced close to their agricultural source, fermented vitamins and minerals, plant-derived colours, antioxidants, and selected flavour operations.
IFF will retain its wider Taste, Scent, Health and Biosciences platforms. The disposal transfers a collection of specialist operations to an owner that intends to make natural and functional ingredients a central part of its growth strategy.
Customers will expect product continuity throughout the ownership change because speciality ingredients are commonly embedded in approved recipes, claims, specifications, and shelf-life programmes. Even where the ingredient name remains unchanged, alterations to manufacturing site, process, raw-material origin, or analytical method can trigger revalidation.
Specifications, regulatory dossiers, quality agreements, certificates, sample libraries, and complaint histories will therefore need to move with the businesses. Commercial continuity also depends on retaining technical employees who understand how individual materials behave within customer products.
Broader portfolios meet more complex formulations
Food manufacturers increasingly ask ingredients to perform several functions at once. A natural colour may need to withstand heat, acidity, light, oxygen, and long storage while supporting a recognisable label and an acceptable cost.
Antioxidants must operate within a finished system shaped by oil composition, headspace, metal ions, packaging barrier, storage temperature, and flavour sensitivity. An ingredient that performs in a laboratory oil sample may behave differently in a baked snack, emulsion, meat product, beverage, or nutritional powder.
Botanical extracts carry additional agricultural variability. Weather, soil, harvest timing, variety, pest pressure, drying, transport, and storage all influence composition before extraction begins, requiring standardisation if manufacturers are to receive consistent performance from one batch to the next.
Producing extracts close to source can reduce the movement of bulky raw plant material and support direct supplier relationships, although it also concentrates exposure to regional weather, infrastructure, regulation, and political conditions.
Fermented vitamins and minerals give the group a different industrial platform. Fermentation requires control over microorganisms, feedstocks, temperature, aeration, contamination, recovery, and purification, while botanical production depends on extraction, separation, concentration, drying, and compositional analysis.
Combining those technologies under one commercial group increases breadth but also creates a more demanding quality system. Facilities operating on three continents must produce documentation, analytical results, and customer service to consistent standards despite using fundamentally different raw materials and processes.
Natural colours illustrate the scale of the technical work behind a seemingly straightforward substitution. Replacing a synthetic colour can alter shade, stability, dosage, flavour, processing sequence, and cost, particularly where plant-based pigments respond to pH or heat.
A successful conversion may require changes to acidification, thermal treatment, light protection, oxygen control, or packaging. Ingredient selection therefore becomes part of the wider process design rather than a simple procurement decision.
Antioxidant replacement follows a similar pattern. Natural materials may bring their own colour, aroma, or flavour, while the dose required for protection can affect the sensory profile of the finished food. Application laboratories and pilot trials are needed to establish a workable balance.
Scale can support that work by spreading investment in analytical laboratories, regulatory teams, sensory capability, clinical evidence, and customer trials across a larger revenue base. A broader manufacturing footprint may also provide alternative supply routes, although specialist plants and region-specific raw materials still create points of concentration.
The acquisition reflects continued consolidation across the ingredients sector, where customers favour suppliers capable of supporting formulation, compliance, and production rather than simply delivering a bag or drum of material.
Larger portfolios create opportunities to combine colours, flavours, antioxidants, nutrients, and botanical actives within one development project. They can also reduce the number of suppliers managed by a manufacturer, provided breadth does not weaken technical depth or responsiveness.
Integration will determine whether those advantages are realised. Information technology, quality systems, legal entities, customer contracts, intellectual property, branding, and procurement arrangements must be separated from IFF and connected to SuanNutra without interrupting supply.
Employee retention will be especially important where product knowledge sits with application scientists, plant operators, regulatory specialists, and commercial teams who have supported the same ingredients for many years.
With more than 1,200 customers and facilities across several regions, the combined business will enter the market with meaningful scale. Its performance will depend on whether it can convert that scale into consistent manufacturing, secure sourcing, and practical formulation support across a technically diverse portfolio.
